Corvus Pharmaceuticals ( $CRVS )
Recent earnings result
- Corvus Pharmaceuticals EPS misses by $0.06
Events & Annual meetings
There are no events at this time for this stock.
For list of CRVS events, you may visit their Investor Relations website.
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers, including refractory renal cell carcinoma and non-small cell lung cancer.
For list of CRVS events, you may visit their Investor Relations website.
Recent results
-
$MGM - MGM Resorts International
MGM Resorts EPS beats by $0.18, misses on revenue
-
$MOH - Molina Healthcare Inc
Molina Healthcare EPS misses by $0.16, misses on revenue
-
$MDRX - Allscripts Healthcare Solutions, Inc.
Allscripts Healthcare Solutions EPS beats by $0.06, beats on revenue
-
$LEAF - Leaf Group
Leaf Group EPS beats by $0.29, beats on revenue
-
$AAPL - Apple
Apple EPS beats by $0.51, beats on revenue, iPhone revenue tops consensus, shares up 5%
-
$CRVS - Corvus Pharmaceuticals
Corvus Pharmaceuticals EPS misses by $0.06
-
$GOOG - Google
Alphabet EPS beats by $1.94, beats on revenue
-
$TEAM - Atlassian Corp PLC A
Atlassian EPS beats by $0.04, beats on revenue
-
$AMZN - Amazon
Amazon EPS beats by $8.80, beats on revenue, AWS revenue falls short
-
$SHAK - Shake Shack Inc
Shake Shack EPS misses by $0.07, misses on revenue